Donate For Public and Patients Store Search

F111 - Neonatal Dermatology: Case-based Discussions

Sunday, March 3; 3:30 PM - 5:30 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Recognize some frequent and infrequent neonatal diseases
  • Identify clues to diagnose potentially severe dermatosis and markers of extracutaneous involvement


In an interactive session we will present common and challenging neonatal cases with emphasis on differential diagnosis and management.


  • Abad, Eugenia, MD: no financial relationships exist with commercial interests.
  • Friedlander, Sheila Fallon, MD: Menlo Therapeutics – A(H); Pfizer Inc. – A(H);
  • Larralde, Margarita M., MD: Eli Lilly and Company – I(H); Galderma Argentina, S.A. – SP(Fees); Genzyme Corporation – SP(Fees); La Roche-Posay Laboratorie Pharmaceutique – SP(Fees); Novartis – I(H); Pierre Fabre Dermatologie – SP(Fees);
  • Luna, Paula Carolina, MD: AbbVie – Speaker/Faculty Education(H); Eli Lilly and Company – I(Fees); Genzyme Corporation – Speaker/Faculty Education(H); La Roche-Posay Laboratorie Pharmaceutique – Speaker/Faculty Education(H); Novartis – I(Fees), Speaker/Faculty Education(H); Pierre Fabre Dermatologie – SP(H); Sanofi – SP(H);
  • Santos Munoz, Andrea, MD: no financial relationships exist with commercial interests.
Event Details
  • Date
    Sunday, March 3
  • Time
    3:30 PM - 5:30 PM
  • Location
    Room 206
  • CME Credits
  • Type
  • Paula Carolina Luna, MD
  • Margarita M. Larralde, MD
  • Andrea Santos Munoz, MD
  • Eugenia Abad, MD
  • Sheila Fallon Friedlander, MD, FAAD